SCHEMBL30554696

SCHEMBL30554696

[C-]#[N+]Cc1c(F)cccc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.43
MAOA P21397 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
MAPK1 P28482 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
KCNH2 Q12809 1/20 0.40
NFE2L2 Q16236 1/20 0.40
LMNA P02545 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29956400 0.80 TAAR1 (0.39) SMN1; SMN2TDP1ALDH1A1
SCHEMBL8418210 0.77 L3MBTL1 (0.47) KDM1AMAOASMN1; SMN2MAPK1L3MBTL1
SCHEMBL29712485 0.76 L3MBTL1 (0.46) KDM1AMAOASMN1; SMN2MAPK1L3MBTL1
SCHEMBL696401 0.76 L3MBTL1 (0.46) KDM1AMAOASMN1; SMN2MAPK1L3MBTL1
SCHEMBL5045894 0.76 L3MBTL1 (0.46) KDM1AMAOASMN1; SMN2MAPK1L3MBTL1
SCHEMBL24685480 0.76 L3MBTL1 (0.46) KDM1AMAOASMN1; SMN2MAPK1L3MBTL1
SCHEMBL16892228 0.76 L3MBTL1 (0.46) KDM1AMAOASMN1; SMN2MAPK1L3MBTL1
SCHEMBL2426746 0.76 CD274 (0.49) KDM1AMAOASMN1; SMN2MAPK1L3MBTL1
SCHEMBL178447 0.76 L3MBTL1 (0.46) KDM1AMAOASMN1; SMN2MAPK1L3MBTL1
SCHEMBL30590652 0.76 L3MBTL1 (0.46) KDM1AMAOASMN1; SMN2MAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4476229-A1 INDUCERS OF KLF2 AND METHODS OF USE THEREOF Riparian Pharmaceuticals, Inc. (US) 2024-12-18 EP disclosed
CN-118974057-A KLF2 inducers and methods of use thereof 里帕里安制药股份有限公司 2024-11-15 CN disclosed
WO-2023150374-A1 INDUCERS OF KLF2 AND METHODS OF USE THEREOF RIPARIAN PHARMACEUTICALS, INC. (US) 2023-08-10 WO disclosed